VeriMomБезопасен ли chitosan salicylate при беременности?
No harmonised CLP classification for reproductive toxicity (ECHA Annex VI) or SCCS/CIR safety finding specific to chitosan salicylate was identified; therefore default hazard is 0. Mechanistic reproductive toxicity data are not available. Dermal use of a salicylate salt can give low but measurable topical absorption of salicylates (salicylic acid), so exposure is scored as low (1). Sources consulted: ECHA Annex VI (no harmonised reproductive classification), PubChem/CosIng listings, absence of SCCS/CIR opinions.
Related ingredients
Frequently asked questions
- Безопасен ли chitosan salicylate при беременности?
- No harmonised CLP classification for reproductive toxicity (ECHA Annex VI) or SCCS/CIR safety finding specific to chitosan salicylate was identified; therefore default hazard is 0. Mechanistic reproductive toxicity data are not available. Dermal use of a salicylate salt can give low but measurable topical absorption of salicylates (salicylic acid), so exposure is scored as low (1). Sources consulted: ECHA Annex VI (no harmonised reproductive classification), PubChem/CosIng listings, absence of SCCS/CIR opinions.
- Безопасен ли chitosan salicylate при грудном вскармливании?
- No evidence of reproductive or lactation-specific toxicity or harmonised classification for chitosan salicylate; systemic maternal transfer would require appreciable absorption. Topical cosmetic use of salicylate salts can result in low systemic exposure, so exposure is scored as low (1). Sources: PubChem/CosIng, ECHA (no harmonised CLP), absence of SCCS/CIR opinions.
- Безопасен ли chitosan salicylate для кожи малыша?
- No infant-specific reproductive or developmental toxicity data were identified and no harmonised classification exists. Because infant skin has higher absorption potential, exposure score is increased by +1 relative to adults to moderate (2) given the presence of a salicylate counterion that can be absorbed; hazard and mechanism remain unsupported by data. Sources: ECHA Annex VI (no harmonised classification), PubChem/CosIng, general dermal absorption principles for infants.
- Как VeriMom оценивает chitosan salicylate?
- VeriMom оценивает chitosan salicylate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы chitosan salicylate при беременности?
- См. наш список безопасных альтернатив chitosan salicylate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.